Earnings Call Summary | ReWalk Robotics(LFWD.US) Q1 2024 Earnings Conference
Earnings Call Summary | ReWalk Robotics(LFWD.US) Q1 2024 Earnings Conference
The following is a summary of the ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript:
以下是ReWalk Robotics Ltd.（LFWD）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
ReWalk reported Q1 2024 sales of $5.3 million, a 340% increase compared to Q1 2023, primarily due to the approval of 14 Medicare claims.
This lead to a reduction in operating losses with a goal to reach breakeven by 2026.
The projected revenue for the full year is expected to be between $28 million and $32 million.
The company had a strong cash position of $20.7 million at the end of the quarter with no outstanding debts.
ReWalk報告稱，2024年第一季度的銷售額爲530萬美元，與2023年第一季度相比增長了340％，這主要是由於14項醫療保險索賠獲得批准。
這減少了營業虧損，目標是到2026年實現盈虧平衡。
全年預計收入將在2,800萬美元至3200萬美元之間。
截至本季度末，該公司的現金狀況良好，爲2,070萬美元，沒有未償債務。
Business Progress:
業務進展：
Pursuing growth strategies, ReWalk aims to process about 100, 200, and 400 systems in 2024, 2025, and 2026 respectively.
A dedicated team is being equipped to handle the growing market demand.
Two new promising products, a new AlterG anti-gravity model and the seventh ReWalk design generation, are in the pipeline.
A new board member has been onboarded for enhanced leadership and market expertise.
Streamlined processes have been put in place for Medicare reimbursements, leading to increased leads and interest in the product. The company continues to drive awareness about product coverage.
爲了實現增長戰略，ReWalk的目標是分別在2024年、2025年和2026年處理約100個、200個和400個系統。
一支專門的團隊已準備就緒，可以應對不斷增長的市場需求。
兩款前景看好的新產品，一種新的AlterG反重力模型和第七代ReWalk設計正在研發中。
一名新的董事會成員已入職，以增強領導力和市場專業知識。
已經簡化了醫療保險報銷流程，從而增加了潛在客戶和對該產品的興趣。該公司繼續提高對產品覆蓋範圍的認識。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。